Apogee Therapeutics Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | — | — | -26.2% |
| FY2023 | — | — | -20.9% |
| FY2024 | — | — | -24.2% |
| FY2025 | — | — | -27.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | — | — | -26.2% |
| FY2023 | — | — | -20.9% |
| FY2024 | — | — | -24.2% |
| FY2025 | — | — | -27.3% |